Cargando…

Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience

OBJECTIVES: The treatments of limbic and other autoimmune encephalitis include immunosuppression, symptomatic treatment, and in the case of paraneoplastic syndromes, appropriate therapy for underlying neoplasms. When immunotherapy is considered, intravenous immunoglobulin is one option for treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinsella, JA, Irani, SR, Hollingsworth, R, O’Shaughnessy, D, Kane, P, Foster, M, Schott, JM, Lunn, MP
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122256/ https://www.ncbi.nlm.nih.gov/pubmed/30202534 http://dx.doi.org/10.1177/2054270418793021

Ejemplares similares

The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis
por: Lee, Soon‐Tae, et al.
Publicado: (2022)

Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin
por: Kim, Ahwon, et al.
Publicado: (2019)

Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
por: Li, Tao-Ran, et al.
Publicado: (2020)

Treatment of West Nile virus encephalitis with intravenous immunoglobulin.
por: Shimoni, Z, et al.
Publicado: (2001)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
por: Perricone, Carlo, et al.
Publicado: (2021)

Autoimmune encephalitis: clinical spectrum and management
por: Uy, Christopher E, et al.
Publicado: (2021)

Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism
por: Connery, Kathleen, et al.
Publicado: (2018)

High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
por: Hoffmann, Jochen H. O., et al.
Publicado: (2019)

Intravenous Immunoglobulin for Management of Non-paraneoplastic Autoimmune Retinopathy
por: Fekri, Sahba, et al.
Publicado: (2020)

Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
por: Velikova, Tsvetelina, et al.
Publicado: (2023)

Clinical audit of core podiatry treatment in the NHS
por: Farndon, Lisa, et al.
Publicado: (2009)

Autoimmune encephalitis: recent clinical and biological advances
por: Varley, James A., et al.
Publicado: (2023)

Randomized Placebo‐Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
por: Dubey, Divyanshu, et al.
Publicado: (2019)

596 Application of Intravenous Immunoglobulin for Treatment of Chronic Autoimmune Urticaria
por: Alyoshkin, Vladimir
Publicado: (2012)

Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses
por: Dourmishev, Lyubomir A., et al.
Publicado: (2016)

Audit on resuscitation equipment in Carseview Centre (NHS Tayside)
por: Leung, Thomas, et al.
Publicado: (2021)

Hippocampal epileptogenesis in autoimmune encephalitis
por: Romoli, Michele, et al.
Publicado: (2019)

346. Eastern Equine Encephalitis and Use of Intravenous Immunoglobulin Therapy and High-Dose Steroids
por: Collens, Sarah I, et al.
Publicado: (2020)

Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review
por: Wagner, Judith N., et al.
Publicado: (2021)

Severe statin-induced autoimmune myopathy successfully treated with intravenous immunoglobulin
por: Güngör, Cansu, et al.
Publicado: (2020)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Autoimmune Encephalitis Misdiagnosis in Adults
por: Flanagan, Eoin P., et al.
Publicado: (2022)

Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments
por: Massa, Federico, et al.
Publicado: (2022)

Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial
por: Hill, Matilda, et al.
Publicado: (2023)

Audit: Medical Seclusion Reviews at Derbyshire Healthcare NHS Foundation Trust
por: Okoro, Esther, et al.
Publicado: (2023)

Autoimmune encephalitis
por: Joob, Beuy, et al.
Publicado: (2016)

A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
por: Rayamajhi, Ajit, et al.
Publicado: (2015)

Opsoclonus myoclonus ataxia may differentiate postinfectious autoimmune encephalitis from infectious encephalitis
por: Lee, Seong-Joon, et al.
Publicado: (2021)

Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients
por: Sharma, Meenu, et al.
Publicado: (2014)

Improvement in Primary Autoimmune Myelofibrosis Following a Short Course of Steroids and Intravenous Immunoglobulins
por: Prakash, Swathi, et al.
Publicado: (2022)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Mimics of Autoimmune Encephalitis: Validation of the 2016 Clinical Autoimmune Encephalitis Criteria
por: Van Steenhoven, Robin W., et al.
Publicado: (2023)

Correction: A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
por: Rayamajhi, Ajit, et al.
Publicado: (2015)

Apheresis in Autoimmune Encephalitis and Autoimmune Dementia
por: Rössling, Rosa, et al.
Publicado: (2020)

The impact of NHS based primary care complementary therapy services on health outcomes and NHS costs: a review of service audits and evaluations
por: Wye, Lesley, et al.
Publicado: (2009)

Posttransplant autoimmune encephalitis
por: Cohen, Devon A., et al.
Publicado: (2018)

Pediatric Autoimmune Encephalitis
por: Barbagallo, Massimo, et al.
Publicado: (2017)

ROSS SYNDROME WITH ANA POSITIVITY: A CLUE TO POSSIBLE AUTOIMMUNE ORIGIN AND TREATMENT WITH INTRAVENOUS IMMUNOGLOBULIN
por: Vasudevan, Biju, et al.
Publicado: (2010)

Optimal Attenuation of Experimental Autoimmune Encephalomyelitis by Intravenous Immunoglobulin Requires an Intact Interleukin-11 Receptor
por: Figueiredo, Carlyn A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gflff7mkfpdptnorm7s91um18e